Sai Life Sciences Ltd company announced its IPO its open date is 11 Dec and its close date is 13 Dec 2024. The company looks good as it is a highly profitable, low-debt company. As per experts, the industry is likely to grow rapidly in the next few years. If you also want to subscribe to it, you should also check Sai Life Sciences IPO GMP Today.
As per experts, the Contract Research, Development, and Manufacturing Organization market is likely to grow by 14% annually till 2028. As per the prediction or analysis, it is a good growth rate for any market or industry. Going with the right stock of the industry can make a huge return.
Free Stocks & IPO GMP
- IPO GMP: Get IPO GMP (Grey Market Premium) of current IPOs directly on WhatsApp.
- Best Stocks: Based on current market and industry conditions, find the best stocks for short-term or long-term investment.
- Free Stocks: Get short-term stocks for short-term investing from top brokers and researchers, including Anand Rathi, Motilal Oswal, Sharekhan, ICICI Securities, Phabhudas Lilladher, and others.
Sai Life Sciences IPO GMP Today
As of 11 Dec 2024, Sai Life Sciences IPO GMP (grey market premium) Today is trading at Rs. 27. As per the GMP, the estimated listing price of the IPO in NSE and BSE is Rs. 576 i.e. (4.92%).
| Date | Live IPO GMP | EST. Listing Gains | Price Band | IPO Size | Bidding Dates |
|---|---|---|---|---|---|
| 12 Dec 2024 (Today) | ₹27 | ₹597 (4.92%) | ₹522 – ₹549 | ₹3,042.62Cr | 11 Dec – 13 Dec 2024 |
Disclaimer: You should not completely rely on the IPO GMP as it is not an accurate indicator, and its trend may change rapidly anytime. Before applying for an IPO, you should check various things like Brokerage or Expert view, Subscription Levels or Status, Risks Involved, Financials, Industry and Market Conditions, Valuations, Company Fundamentals, Promoters and management, etc.
About Sai Life Sciences Ltd
Sai Life Sciences Ltd was founded in 1999. The company is engaged in the business of Contract Research, Development, and Manufacturing Organization for the pharmaceutical and biotechnology industry.
Sai Life Sciences Ltd’s manufacturing facilities are located in the US, UK, and India. Locations are Discovery Biology Lab (Greater Boston, USA), Process R&D Lab (Manchester, UK), Integrated Campus Hyderabad, and API Manufacturing Facility, Bidar, India.
Sai Life Sciences Ltd IPO Details
Sai Life Sciences Ltd IPO open date from 11 Dec and close on 13 Dec 2024. The IPO price band is set from Rs. 522 to Rs. 549. The issue size of the IPO is nearly Rs. 3,042.62 Crores. The allotment date of the Sai Life Sciences IPO is 16 December 2024 and it will be listed on 18 December 2024.
| IPO Type | Mainboard |
| IPO Open Date | 11 Dec 2024 |
| IPO Close Date | 13 Dec 2024 |
| IPO Listing Date | 18 Dec 2024 |
| IPO Refund Date | 17 Dec 2024 |
| IPO Allotment Date | 16 Dec 2024 |
| IPO Demat Credit Date | 17 Dec 2024 |
| IPO Price Band | ₹522 to ₹549 Per Share |
| IPO Listing | NSE & BSE |
| Issue Size | Approx ₹3,042.00 Crores |
| Fresh Issue | Approx ₹950.00 Crores |
| Offer For Sale | Approx 38,116,934 Equity Shares |
| NII Quota | Not More Than 15% |
| QIB Quota | Not More Than 50% |
| Retail Quota | Not More Than 35% |
| Prospectus | Click Here |
Profit & Loss
Sai Life Sciences Ltd publically disclosed 2 half-yearly results for Sep 2023 and Sep 2024. In the Sep 2023, the company reported sales of 642 and a net loss of Rs. 13 Crores. In Sep 2024, the company reported a net profit of Rs. 28 Crores and 675 sales.
The company also published 6 years of annual profit and loss data from March 2019 and March 2021 to March 2024.
In March 2019, the company reported a net profit of Rs. 73 Crores, In March 2021 net profit of Rs. 61 Crores, In March 2022 net profit of Rs. 6 Crores, In March 2023 net profit of Rs. 10 Crores, and in March 2024 net profit of Rs. 83 Crores.
FAQs
Currently, 5 years of annual profit and loss data of the company is available publically. As per the available data, it is a profitable company and from the last 3 FYs, the net profits of the company have also improved.
Available annual profits of the company are In March 2019, the company reported a net profit of Rs. 73 Crores, In March 2021 net profit of Rs. 61 Crores, In March 2022 net profit of Rs. 6 Crores, In March 2023 net profit of Rs. 10 Crores, and in March 2024 net profit of Rs. 83 Crores.
There is a debt of Rs. 992 Crores and its debt-to-equity is 0.95. In short, it’s a low-debt company.
The company is engaged in the business of Contract Research, Development, and Manufacturing Organization for the pharmaceutical and biotechnology industry.
As of 12 December 2024, the Sai Life Sciences IPO GMP (grey market premium) is trading at Rs. 27 which means the estimated listing price of the IPO is Rs. 576 (4.92%).
Conclusion
Sai Life Sciences Ltd is engaged in the business Contract Research, Development, and Manufacturing Organization for the pharmaceutical and biotechnology industry. It is a low-debt profitable company, and the net profit of the company has also improved in the last 3 years. As of 12 December 2024, Sai Life Sciences IPO GMP is trading at Rs. 27.